Berry Genomics Co.,Ltd (SHE:000710)
China flag China · Delayed Price · Currency is CNY
9.42
+0.21 (2.28%)
Nov 2, 2026, 3:04 PM CST

Berry Genomics Co.,Ltd Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
200.5379.51383.07338.15333.56417.89
Trading Asset Securities
2.822.8217.0313.864.513.82
Cash & Short-Term Investments
203.32382.33400.1352.01338.07421.7
Cash Growth
-36.51%-4.44%13.66%4.12%-19.83%-33.39%
Accounts Receivable
554.82549.34695.17815.211,0631,109
Other Receivables
52.8756.0576.454.9714.5134.07
Receivables
607.7605.38771.62820.181,0771,143
Inventory
170.23176.76194.91229.3230.95233.88
Prepaid Expenses
-0.080.010.140.211.88
Other Current Assets
109.9779.5272.4571.3780.15105.88
Total Current Assets
1,0911,2441,4391,4731,7271,907
Property, Plant & Equipment
495.27519.91459.07923.421,1011,131
Long-Term Investments
196.71187.75177.1948.45138.26279.07
Goodwill
13.4313.4313.4313.4313.4313.43
Other Intangible Assets
64.9866.431.6849.6751.652.21
Long-Term Accounts Receivable
--0.31---
Long-Term Deferred Tax Assets
148.18150.42144.07151.27104.863.93
Long-Term Deferred Charges
107.86102.2489.7748.4441.0446.71
Other Long-Term Assets
--30.1133.4926.6627.05
Total Assets
2,1182,2842,3852,7413,2033,520

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
235.91272.91287.51292.48278.9339.93
Accrued Expenses
38.1952.4155.8164.9563.1466.16
Short-Term Debt
138.06154.32113.42202.64203.69190.54
Current Portion of Long-Term Debt
9.12--42.3--
Current Portion of Leases
-11.553.6312.95139.44
Current Income Taxes Payable
9.382.913.911.910.3813.44
Current Unearned Revenue
125.62119.66103.49110.75103.5690.55
Other Current Liabilities
14.3322.2422.8125.1142.0558.52
Total Current Liabilities
570.62635.99590.56763.09704.72768.58
Long-Term Debt
10--42.18126.6185.7
Long-Term Leases
98.87107.2943.243.54.8813.62
Long-Term Unearned Revenue
11.0310.9410.8711.0212.073.66
Long-Term Deferred Tax Liabilities
24.9225.9224.926.7725.8924.46
Total Liabilities
745.43780.14669.56846.56874.17996.02

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
353.52353.52353.52353.52354.61354.61
Additional Paid-In Capital
1,1581,1631,1591,1561,2111,160
Retained Earnings
-158.79-56.32145.39337.82765.021,020
Treasury Stock
-----44.52-44.52
Comprehensive Income & Other
6.2116.4121.116.515.390.63
Total Common Equity
1,3591,4761,6791,8642,3012,490
Minority Interest
12.9627.8535.6930.5727.9433.51
Shareholders' Equity
1,3721,5041,7151,8952,3292,524
Total Liabilities & Equity
2,1182,2842,3852,7413,2033,520

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
256.05273.15160.28303.58348.17399.3
Net Cash (Debt)
-52.73109.18239.8248.43-10.1122.4
Net Cash Growth
--54.47%395.21%---91.81%
Net Cash Per Share
-0.150.310.680.14-0.030.06
Filing Date Shares Outstanding
353.27353.52353.52353.52353.52353.52
Total Common Shares Outstanding
353.27353.52353.52353.52353.52353.52
Working Capital
520.59608.09848.53709.91,0221,138
Book Value Per Share
3.854.184.755.276.517.04
Tangible Book Value
1,2811,3961,6341,8012,2362,425
Tangible Book Value Per Share
3.633.954.625.096.336.86
Buildings
-317.47317.47606.22684.23684.08
Machinery
-647.34623.32638.82591.45553.45
Construction In Progress
-9.51-230.8290.95267.6